India Disposable Syringes Market 2025 – 2034

Reports Description

The India Disposable Syringes Market is forecast to grow at a CAGR of 13.96% from 2025 to 2034. The market is expected to reach USD 1,470.0 Million by 2034, up from USD 452.34 Million in 2025.

To learn more about this report - request a sample report PDF

Overview

This growth is indicative of the growing adoption of injectable medications and increasing demand for sustainable and disposable medication solutions.

Key Trends & Drivers

The India Disposable Syringes Market Trends have tremendous growth opportunities due to several factors

• Growing Adoption of Injectable Medications: The increasing adoption of Injectable medications in India due to the increasing aging population, growing disease burden, and increasing number of patients with cardiovascular diseases is expected to drive the demand for syringes during the forecast period. India is witnessing an escalation of cases of diabetes, obesity, cardiovascular disorders, cancer, and other chronic conditions. For instance, according to the data published by the Indian Council of Medical Research, overweight and obesity affect more than 24% of women and 23% of men aged 15– to 49 up significantly from earlier years due to unhealthy lifestyle and disease burden. Furthermore, the number of adults with diabetes is projected to increase from 74.2 Mn in 2021 to more than 124 Mn in 2045 due to the increasing aging population. The increasing disease burden This growing disease burden naturally increases demand for injectable treatments like insulin, biologics, chemotherapy agents, and newer therapies. Thus, such a surge in disease burden is expected to drive the demand for disposable syringes during the forecast period.

• Increasing Demand for Sustainable and Disposable Solutions: The demand for sustainable and eco-friendly products and solutions is increasing across India due to growing environmental awareness and increasing emphasis on sustainable development practices. Furthermore, India's large-scale immunization efforts, such as the Universal Immunization Programme (UIP), Mission Indradhanush, and COVID‑19 vaccination drives, are expected to drive the demand for disposable syringes across India during the forecast period, thereby driving the market growth. The Government of India has launched the Ayushman Bharat, and along with investments in hospitals and diagnostic centers, they are expanding healthcare access, resulting in greater syringe demand.

Restraints

• High Cost of the Disposable Syringes: The Disposable Syringes are made of polypropylene, polyethylene, Polyisoprene, medical-grade plastics, stainless steel, and a synthetic rubber sealant. The specific components are manufactured separately before being assembled and sterilized. The prices of these raw materials are fluctuating periodically due to the increasing cost of these raw materials and supply chain disturbances. International polymer markets often impact India’s import costs, even when domestic suppliers are available. Furthermore, manufacturing of these syringes requires high-end machines and skilled labour. Additionally, the medical equipment manufacturing industry is highly regulated and requires high costs to comply with these regulations, thereby increasing overall production costs. The overdependence on imports for many high-grade raw materials, especially for needles, plunger tips, and lubricants, is expected to increase the overall production cost. Even minor customs duties or delays at ports increase costs for manufacturers. ‌

• Less Adoption in Many Undeveloped States: The less adoption in many underdeveloped states and rural areas is mainly restraining the market growth. The many rural and remote clinics and informal health workers still reuse syringes, often unknowingly. Furthermore, lack of awareness of training and awareness about infections and diseases such as HIV, Hepatitis B/C caused by reuse reduces demand for safe single-use syringes. The disposable syringes are often considered expensive compared to reusable ones, especially in low-income regions. Furthermore, budget limitations in public hospitals and clinics due to lack of revenues and funds are making the procurement inconsistent, thereby reducing the market growth. Weak healthcare infrastructure across India due to the poor distribution networks and supply chain inefficiencies limits the availability of disposable syringes in rural and remote areas. The stockouts and inconsistent supply force practitioners to rely on unsafe alternatives and are expected to restrain the market growth.

Opportunities

• Increasing awareness of Disease Transmission Risks: Growing awareness of disease transmission risks has pushed various end users and stakeholders, such as hospitals, clinics, labs, and healthcare camps, toward single-use, safety-engineered syringes, such as retractable or auto-disable types. These syringes help reduce needle-stick injuries and cross-contamination. Prefilled and auto-disable variants are particularly in demand for safety and convenience.

• Eco-friendly Designs awareness: The growing awareness about eco-friendly and sustainable solutions due to increasing stringent regulations and awareness about pollution is pushing the demand for sustainable disposables. Thus, there is such a growing push for sustainable disposables, including biodegradable materials and eco-conscious designs. While still emerging, this trend aligns with broader concerns about medical waste and environmental impact.

• ‌Technological Advancements in Syringe Manufacturing: The key players operating in the market are increasingly focusing on integrating advanced machinery and technologies to improve designs—prefilled syringes, auto-disable models, and even needle-free options developed by Indian research institutions. These innovations improve usability, safety, and adherence. Furthermore, growing integration of robotics, AI and automation technologies in the manufacturing facilities is expected to create lucrative opportunities for the market growth. The robotic integrated assembly lines can handle syringe component handling, assembly, loading, unloading, and packaging with precision, trimming human error and boosting throughput. Advanced technologies such as Artificial intelligence and machine learning and predictive analytics provide real-time insights and optimization in predicting maintenance needs, analysing defects, and fine-tuning production parameters for enhanced efficiency and consistency. Thus, growing integration of advanced technologies is expected to create lucrative opportunities for the market growth during the forecast period.

Impact of Recent Tariff Policies

The Trump-led U.S. government has imposed the reciprocal tariffs on various medical equipment and devices. India imports a large volume of syringes from the European and North American countries, about USD 95 Mn annually; thus, any tariff change has an immediate market impact. The regulatory bodies have been pushing for higher import duties (safeguard/anti-dumping) to protect local manufacturers after imports rose sharply in recent years. Thus, the tariff is increasing the landing and selling prices of the imported syringes, causing a potential supply disruption for hospitals/clinics; in the medium term, they can encourage domestic production if supported by complementary policies.

The hefty tariffs are reducing the import competition and encouraging the local manufacturers to scale up and invest in capacity, quality, and certifications. Indian medtech bodies have explicitly sought higher duties to preserve domestic industry capacity. But protection without quality and scale support risks allowing higher-priced, lower-quality products.

Report Scope

Country Analysis

The India Disposable Syringes market is segmented into North India, South India, East India, and West India.

• West India: This region held the highest market share in 2024 and is expected to keep its dominance during the forecast period owing to the presence of well-established hospital and clinic chains in Maharashtra, Gujarat, Madhya Pradesh, and Goa. Maharashtra is the leading state in the Western region due to the presence of a well-established healthcare industry and increasing awareness about healthcare.

• East India: This region includes Bihar, Jharkhand, Odisha, West Bengal, and the Northeast states. The rapidly increasing investment by the key players in this region and growing emphasis by the respective state governments on the healthcare facility expansion. For instance, under the Ayushman Bharat scheme, thousands of Health & Wellness Centres have been upgraded in eastern states; for instance, more than 12,000 HWCs in Bihar and 11,000 in West Bengal have been upgraded in these states. Thus, such factors are expected to drive the market growth of this region.

• South India: The south India includes Andhra Pradesh, Telangana, Karnataka, Kerala, and Tamil Nadu. South India is considered the medical hub of India. The major pharmacy and medical cities such as Chennai, Bengaluru, Hyderabad, and Kochi are major referral centers, attracting both domestic and international patients. South India has a large number of ambulatory care centers. South India leads in day-care surgeries and diagnostics, driving higher per capita syringe usage compared to eastern/northern states.

• North India: Delhi, Haryana, Punjab, Himachal Pradesh, Uttarakhand, Uttar Pradesh, Rajasthan, J&K, Ladakh, and Chandigarh are all considered to be part of North India. Due to the historically low vaccination rates in Uttar Pradesh and the Bihar belt, which are part of North India, a lot of disposable and auto-disposable syringes are used in polio, maternal-child health, and Mission Indradhanush programs. Pulse polio campaigns:During polio eradication efforts, Uttar Pradesh has been one of the states that uses the most syringes. Vitamin supplements, oxytocin, iron sucrose, and other maternal and pediatric health injections are important sources of demand.

Key Developments

• In February 2025, BD separated its Biosciences & Diagnostic Solutions business to increase its focus on medical technology and site-specific priorities like syringes, needles, catheters, and blood collection devices.

• In October 2023, B. Braun made an investment in Mexico’s production facility to expand its syringe production facility aimed at increasing output with advanced automation and improved quality but this is not an Indian development.

• ‌In 2024, B. Braun acquired the Clik-FIX catheter securement portfolio, expanding in infusion therapy and pain management, again at a global level.

Leading Players

The India Disposable Syringes Market is highly competitive, with a large number of product providers in India. Some of the key players in the market include:

• Becton Dickinson Private Limited
• ‌B. Braun Medical (India) Pvt. Ltd.
• ‌Terumo India Private Limited
• ‌Teleflex Medical Private Limited
• ‌Nipro India Corporation Pvt. Ltd.
• ‌Novo Nordisk India Private Limited
• ‌Cardinal Health International India Pvt Ltd
• ‌Hindustan Syringes & Medical Devices Ltd.
• ‌Baxter Pharmaceuticals India Private Limited
• ‌Albert David Limited
• Others

These firms apply a sequence of strategies to enter the market, including innovations, mergers, and acquisitions, as well as collaboration.

The India Disposable Syringes Market is segmented as follows:

By Type

• Conventional Syringes
• Pre-Filled Syringes
• Safety Syringes

By Material

• Glass
• Polymer

By Application

• General Surgery
• Diagnostic
• Therapeutic
• Respiratory
• Orthopedics
• Cardiovascular
• Dental
• Others

By End User

• Hospitals and Clinics
• Ambulatory Care Centers
• Others